Login
$SACH
$0.83 +$0.00 (0.5%) Close

$SACH 4 SEC Filings

Filed On Filing
05 Sep 2025 Form 4: Walraven Jeffery C, EVP and CFO

Received 236,220 shares as a grant or award

13 Aug 2025 Form 4: Villano John L., Director

Received 112,613 shares as a grant or award

04 Aug 2025 Form 4: Prinz Brian A, Director

Received 17,241 shares as a grant or award

04 Aug 2025 Form 4: Goldberg Arthur L, Director

Received 17,241 shares as a grant or award

24 Mar 2025 Form 4: Villano John L., Director

Disposed of 420,168 shares (Other Transaction)

11 Mar 2025 Form 4: Walraven Jeffery C, Director

Received 20,000 shares as a grant or award

11 Mar 2025 Form 4: Villano John L., Director

Received 420,168 shares as a grant or award

11 Mar 2025 Form 4: Prinz Brian A, Director

Received 20,000 shares as a grant or award

11 Mar 2025 Form 4: Goldberg Arthur L, Director

Received 20,000 shares as a grant or award

21 Nov 2024 Form 4: Villano John L., Director

Bought 124,660 shares ($201K)

20 Mar 2024 Form 4: Villano John L., Director

Received 111,857 shares as a grant or award

27 Nov 2023 Form 4: Bernhard Leslie, Director

Sold 2,750 shares ($9.86K)

17 Nov 2023 Form 4: Bernhard Leslie, Director

Sold 1,900 shares ($6.82K)

11 Sep 2023 Form 4: Bernhard Leslie, Director

Received 6,000 shares as a grant or award

11 Sep 2023 Form 4: Prinz Brian A, Director

Received 6,000 shares as a grant or award

11 Sep 2023 Form 4: Goldberg Arthur L, Director

Received 6,000 shares as a grant or award

16 May 2023 Form 4: Prinz Brian A, Director

Bought 3,175 shares ($10.1K)

21 Feb 2023 Form 4: Villano John L., Director

Received 130,890 shares as a grant or award

15 Feb 2023 Form 4: Warch John E, See Remarks

Received 8,000 shares as a grant or award

14 Nov 2022 Form 4: Bernhard Leslie, Director

Sold 1,850 shares ($6.92K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support